PATENT CLAIM ANALYSIS

Application Number: 16529400
Application Type: Utility
Filing Date: 2019-08
Publication Date: 2019-11
Patent Classification: ["514", "401000"]

Abstract:
Disclosed is a single unit oral dosage form having, in combination, inositol and an extended release clonidine or extended release guanfacine. In one aspect, a method for treating ADHD and/or associated symptoms thereof includes administering to an ADHD patient the single unit oral dosage form. In another aspect, a method for treating ADHD and/or associated symptoms thereof includes administering to an ADHD patient inositol in combination with extended release clonidine or extended release guanfacine, whether administered separately or as a single dosage form.

Claim (Index 35):
The method of  claim 32 , wherein the dosage form is provided as a comestible.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 100.0
- Lexical Diversity: 2.11628
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14245121', '13860824', '15346079', '13656415', '15102871']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.789467300558159
- 35 USC 102 Novelty (BERT): 0.572939036923312
- Combined Prediction Score: 0.7678144741946743
- Mean Citation Score: 386.91969
- Max Citation Score: 559.2398
- Similarity Product: 339.61415466263287

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test